Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis

Hepatology

Volumn 32, Issue 2, 2000, Pages 334-340

  Kinnman, Nils ^a,c   Lindblad, Anders ^b   Housset, Chantal ^c   Buentke, Eva ^a   Scheynius, Annika ^a   Strandvik, Birgitta ^b   Hultcrantz, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; BILE DUCT; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; STELLATE CELL;

EID: 0033865897     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.9111     Document Type: Article

References (51)

1. Liver and biliary problems in cystic fibrosis
2. Cystic fibrosis patients with liver disease are not genetically distinct [letter]
3. Genotype-phenotype correlation in cystic fibrosis patients
4. Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease
5. Analysis of risk factors for the development of liver disease associated with cystic fibrosis
6. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis
7. Natural history of liver disease in cystic fibrosis
8. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
9. Identification of the cystic fibrosis gene: Chromosome walking and jumping
10. Identification of the cystic fibrosis gene: Genetic analysis
11. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)
12. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity
13. The molecular basis for disease variability in cystic fibrosis
14. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells
15. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells
16. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
17. Immunocytochemical analysis reveals differences between the subcellular localization of normal and ΔPhe508 recombinant cystic fibrosis transmembrane conductance regulator
18. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland
19. ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis
20. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients
21. Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study
22. Bile-duct destruction and collagen deposition: A prominent ultrastructural feature of the liver in cystic fibrosis
23. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis- associated liver disease
24. A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas: Recognition through signs of portal hypertension
25. The pathological changes in the liver in cystic fibrosis of the pancreas
26. Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosis
27. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: An autopsy study in cystic fibrosis
28. One-second needle biopsy of the liver
29. Alkaline phosphatase-Fast red: A new fluorescent label
30. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes
31. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation
32. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
33. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
34. Submucosal glands are the predominant site of CFTR expression in the human bronchus
35. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium
36. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment
37. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing
38. Degradation of CFTR by the ubiquitinproteasome pathway
39. Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro
40. Genetic determination of exocrine pancreatic function in cystic fibrosis
41. The relation between genotype and phenotype in cystic fibrosis- analysis of the most common mutation (delta F508)
42. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis
43. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: Effect of proinflammatory cytokines
44. Molecular regulation of hepatic fibrogenesis
45. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells
46. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells
47. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats